Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Implication for bone marrow derived stem cells in hepatocyte regeneration after orthotopic liver transplantation.

Pilat N, Unger L, Berlakovich GA.

Int J Hepatol. 2013;2013:310612. doi: 10.1155/2013/310612. Review.

2.

Pre-vascularization of bone tissue-engineered constructs.

Brennan M, Davaine JM, Layrolle P.

Stem Cell Res Ther. 2013 Aug 14;4(4):96. doi: 10.1186/scrt307.

3.

In vivo tracking and comparison of the therapeutic effects of MSCs and HSCs for liver injury.

Li Q, Zhou X, Shi Y, Li J, Zheng L, Cui L, Zhang J, Wang L, Han Z, Han Y, Fan D.

PLoS One. 2013 Apr 30;8(4):e62363. doi: 10.1371/journal.pone.0062363.

4.

The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine.

Bianco P, Cao X, Frenette PS, Mao JJ, Robey PG, Simmons PJ, Wang CY.

Nat Med. 2013 Jan;19(1):35-42. doi: 10.1038/nm.3028.

5.

Stem cell recruitment after injury: lessons for regenerative medicine.

Rennert RC, Sorkin M, Garg RK, Gurtner GC.

Regen Med. 2012 Nov;7(6):833-50. doi: 10.2217/rme.12.82. Review.

6.

Adipose derived mesenchymal stem cells transplantation via portal vein improves microcirculation and ameliorates liver fibrosis induced by CCl4 in rats.

Wang Y, Lian F, Li J, Fan W, Xu H, Yang X, Liang L, Chen W, Yang J.

J Transl Med. 2012 Jun 26;10:133. doi: 10.1186/1479-5876-10-133.

7.

Adult stem cell mobilization enhances intramembranous bone regeneration: a pilot study.

McNulty MA, Virdi AS, Christopherson KW, Sena K, Frank RR, Sumner DR.

Clin Orthop Relat Res. 2012 Sep;470(9):2503-12. doi: 10.1007/s11999-012-2357-9.

8.

Selective Expansion of CD34+ Cells from Mouse Bone Marrow Cultured on LH/P MP-Coated Plates with Adequate Cytokines.

Kishimoto S, Ishihara M, Kanatani Y, Nambu M, Takikawa M, Sumi Y, Nakamura S, Mori Y, Hattori H, Tanaka Y, Sato T.

J Tissue Eng. 2011;2(1):2041731411425419. doi: 10.1177/2041731411425419.

9.

Delivery of VEGF using collagen-coated polycaprolactone scaffolds stimulates angiogenesis.

Singh S, Wu BM, Dunn JC.

J Biomed Mater Res A. 2012 Mar;100(3):720-7. doi: 10.1002/jbm.a.34010.

10.

In vitro model of vascularized bone: synergizing vascular development and osteogenesis.

Correia C, Grayson WL, Park M, Hutton D, Zhou B, Guo XE, Niklason L, Sousa RA, Reis RL, Vunjak-Novakovic G.

PLoS One. 2011;6(12):e28352. doi: 10.1371/journal.pone.0028352.

11.

Mesenchymal stromal cell mutations and wound healing contribute to the etiology of desmoid tumors.

Carothers AM, Rizvi H, Hasson RM, Heit YI, Davids JS, Bertagnolli MM, Cho NL.

Cancer Res. 2012 Jan 1;72(1):346-55. doi: 10.1158/0008-5472.CAN-11-2819.

12.

Biomaterial implants mediate autologous stem cell recruitment in mice.

Nair A, Shen J, Lotfi P, Ko CY, Zhang CC, Tang L.

Acta Biomater. 2011 Nov;7(11):3887-95. doi: 10.1016/j.actbio.2011.06.050.

13.

Endothelial progenitor cells are integrated in newly formed capillaries and alter adjacent fibrovascular tissue after subcutaneous implantation in a fibrin matrix.

Bleiziffer O, Hammon M, Naschberger E, Lipnik K, Arkudas A, Rath S, Pryymachuk G, Beier JP, St├╝rzl M, Horch RE, Kneser U.

J Cell Mol Med. 2011 Nov;15(11):2452-61. doi: 10.1111/j.1582-4934.2010.01247.x.

14.

Clones of ectopic stem cells in the regeneration of muscle defects in vivo.

Yang R, Chen M, Lee CH, Yoon R, Lal S, Mao JJ.

PLoS One. 2010 Oct 20;5(10):e13547. doi: 10.1371/journal.pone.0013547.

15.

At the edge of translation - materials to program cells for directed differentiation.

Arany PR, Mooney DJ.

Oral Dis. 2011 Apr;17(3):241-51. doi: 10.1111/j.1601-0825.2010.01735.x. Review.

16.
17.

Hybrid adipogenic implants from adipose stem cells for soft tissue reconstruction in vivo.

Moioli EK, Chen M, Yang R, Shah B, Wu J, Mao JJ.

Tissue Eng Part A. 2010 Nov;16(11):3299-307. doi: 10.1089/ten.TEA.2010.0157.

18.

Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in diseases of the skeleton.

Chanda D, Kumar S, Ponnazhagan S.

J Cell Biochem. 2010 Oct 1;111(2):249-57. doi: 10.1002/jcb.22701. Review.

19.

Cell therapy of congenital corneal diseases with umbilical mesenchymal stem cells: lumican null mice.

Liu H, Zhang J, Liu CY, Wang IJ, Sieber M, Chang J, Jester JV, Kao WW.

PLoS One. 2010 May 19;5(5):e10707. doi: 10.1371/journal.pone.0010707.

20.

Angiogenic and osteogenic potential of bone repair cells for craniofacial regeneration.

Kaigler D, Pagni G, Park CH, Tarle SA, Bartel RL, Giannobile WV.

Tissue Eng Part A. 2010 Sep;16(9):2809-20. doi: 10.1089/ten.TEA.2010.0079.

Items per page

Supplemental Content

Support Center